Device embolization is a rare complication of transcatheter structural heart interventions.
Although the majority of device embolizations can be treated in a semielective manner …

Hemolysis is an unintended sequel of temporary or permanent intracardiac devices.
However, limited data exist on the characteristics and treatment of hemolysis in patients with …

Purpose of review As the number of surgical and transcatheter valve replacements continue
to increase in the aging population, so does the incidence of paravalvular leak (PVL). Given …

Paravalvular leak (PVL) is a complication that occurs in 5–17% of patients after surgical
prosthetic valve implantation. Whereas PVLs can be benign, some PVLs are associated with …

Objective To study the effect of percutaneous paravalvular leak closure on hemolysis.
Background Although transcatheter PVL closure reduces heart failure and mortality in …

Introduction A significant paravalvular leak (PVL) is estimated in at least 1–3% of patients
undergoing surgical aortic and/or mitral valve replacement. Surgical repair of a PVL is …

The incidence of aortic paravalvular leaks after surgical valve replacement is estimated to be
2-17%. Aortic paravalvular leaks (PVL) can be asymptomatic and not require treatment or …

Paravalvular leak (PVL) is a common and challenging problem that has existed since
prosthetic cardiac valves were first implanted. PVL occurs in 7-17% of mitral valve …

Paravalvular leak (PVL) is a common condition in which an unintended gap between a
prosthetic heart valve and native annular tissue allows for regurgitation of blood from a …

V roku 2017 boli publikované nové spoločné odporúčania Európskej kardiologickej
spoločnosti (ESC) a Európskej asociácie hrudných chirurgov (EACTS) pre manažment …